| Innovation Pharma Services Ltd |
| Registered number: |
07512773 |
| Balance Sheet |
| as at 27 February 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
3 |
|
|
816 |
|
|
1,020 |
|
| Current assets |
| Cash at bank and in hand |
|
|
248 |
|
|
4,815 |
|
| Creditors: amounts falling due within one year |
4 |
|
(542) |
|
|
(5,515) |
|
| Net current liabilities |
|
|
|
(294) |
|
|
(700) |
|
| Net assets |
|
|
|
522 |
|
|
320 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
422 |
|
|
220 |
|
| Shareholder's funds |
|
|
|
522 |
|
|
320 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The member has not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
| Richard Gibbs |
| Director |
| Approved by the board on 6 October 2025 |
|
| Innovation Pharma Services Ltd |
| Notes to the Accounts |
| for the year ended 27 February 2025 |
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
2 |
|
2 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
|
|
|
|
Plant and machinery |
| £ |
|
Cost |
|
At 28 February 2024 |
2,726 |
|
At 27 February 2025 |
2,726 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 28 February 2024 |
1,706 |
|
Charge for the year |
204 |
|
At 27 February 2025 |
1,910 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 27 February 2025 |
816 |
|
At 27 February 2024 |
1,020 |
|
|
| 4 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Corporation tax |
330 |
|
1,598 |
|
Other taxes and social security costs |
924 |
|
- |
|
Director loan account |
(1,162) |
|
435 |
|
Accruals |
450 |
|
450 |
|
Other creditors |
- |
|
3,032 |
|
|
|
|
|
|
542 |
|
5,515 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Other information |
|
|
Innovation Pharma Services Ltd is a private company limited by shares and incorporated in England. Its registered office is: |
|
Lime Tree House |
|
Top Road |
|
Slindon |
|
West Sussex |
|
BN18 0RP |